ACI Formulations PLC (DSE:ACIFORMULA)
136.00
-1.00 (-0.73%)
At close: Jul 21, 2025
ACI Formulations Revenue
ACI Formulations had revenue of 1.30B BDT in the quarter ending March 31, 2025, with 5.39% growth. This brings the company's revenue in the last twelve months to 5.01B, up 0.65% year-over-year. In the fiscal year ending June 30, 2024, ACI Formulations had annual revenue of 4.94B, down -0.49%.
Revenue (ttm)
5.01B
Revenue Growth
+0.65%
P/S Ratio
1.28
Revenue / Employee
4.84M
Employees
1,034
Market Cap
6.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 4.94B | -24.35M | -0.49% |
Jun 30, 2023 | 4.96B | 712.39M | 16.77% |
Jun 30, 2022 | 4.25B | 382.88M | 9.91% |
Jun 30, 2021 | 3.86B | 440.49M | 12.86% |
Jun 30, 2020 | 3.42B | -628.33M | -15.51% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Grameenphone | 156.27B |
Square Pharmaceuticals PLC. | 75.86B |
British American Tobacco Bangladesh Company | 98.15B |
BRAC Bank PLC. | 65.27B |
Robi Axiata PLC. | 97.75B |
Walton Hi-Tech Industries | 78.24B |
Bangladesh Export Import Company | 17.72B |
Marico Bangladesh | 16.31B |